| Literature DB >> 16261559 |
C Furth1, H Amthauer, T Denecke, J Ruf, G Henze, M Gutberlet.
Abstract
In patients with Ewing sarcoma, precise staging is not only crucial for the therapeutic regimen but also for a reliable evaluation of response to therapy. We report on a 15-year-old girl with metastatic spread of a Ewing sarcoma who, apart from conventional staging by bone scan, chest X-ray and CT, was subsidiary examined by FDG-PET and whole-body MRI before and after chemotherapy. Both modalities detected more bone lesions than the bone scan, which led to an altered strategy for radiotherapy. Both examinations might be a great asset to stage-adjusted therapy regimens, ultimately influencing patient outcome. Copyright (c) 2005 Wiley-Liss, Inc.Entities:
Mesh：
Year: 2006 PMID： 16261559 DOI： 10.1002/pbc.20662
Source DB: PubMed Journal: Pediatr Blood Cancer ISSN： 1545-5009 Impact factor: 3.167